Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03305445
Title Nivolumab/Ipilimumab-Primed Immunotransplant for DLBCL
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Icahn School of Medicine at Mount Sinai
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.